BMGFGrants

Updated 15 November, 2021

GRANT ID GRANTEE PURPOSE DATE COMMITTED DURATION (MONTHS) AMOUNT COMMITTED GRANTEE COUNTRY

INV-031449 Cancer Hospital, Chinese Academy of Medical Sciences to fund the implementation research, planning and technical assistance of implementing the pilots of HPV EPI introduction and cervical cancer elimination in cities and low resource regions in China 2021-11 22 1550000 China

INV-034472 Fudan University Education Development Foundation, Shanghai to support a research of bacterial infection surveillance and evaluate the vaccine impact to the population of children and the elderly in community post Pneumococcal Conjugate Vaccine (PCV) introduction in children 2021-11 16 1229760 China

INV-035022 Chinese Preventive Medicine Association to advocate for evidence-based policies and scale up new TB control models to improve prevention and control of TB 2021-11 34 690000 China

INV-004143 Beijing Normal University to organize a series of seminars to collect and consolidate researchers and practitioners’ feedback on the implementation of Charity Law to help policy makers working on the Charity Law amendment gain a full and fair view 2021-10 7 50000 China

INV-033236 Institute of Crop Sciences, Chinese Academy of Agricultural Sciences to leverage China's experience in rice research and production accumulated to help African countries establish rice seed system that support productivity growth in rice commodities and maintain long term food security and self-su
2021-10ciency. 30 1550000 China

INV-031020 China Science and Technology Exchange Center to enhance China’s research and development contribution to global health and development by strengthening partnerships with the government, industry, and academia 2021-10 11 150000 China

INV-035302 Tsinghua University To provide scienti c evidences about new vax introduction and the optimization of immunization service to proactively address issues of vaccine coverage and scheduling challenges when EPI expands 2021-09 18 180188 China

INV-035190 China Agricultural University to build an enabling environment for supporting China’s engagement in global health and development as a global public good provider with the ultimate goal of helping those who are su ering from infectious diseases, hunger2021-09
and poverty 23 300000 China

INV-035024 Peking University to support establish the methodology of the pharmacovigilance real world research to improve China’s pharmacovigilance capacity 2021-09 47 800004 China

INV-036000 China Primary Health Care Foundation to drive public awareness of ISO-compliant non-sewer sanitation technology’s contribution to public health to facilitate industry development and mass adoption in China for the bene t of poor people living in underserved regions
2021-09 15 895554 China

INV-027420 Institute of Microbiology, Chinese Academy of Sciences to support the screening and evaluation of adjuvants and technical platforms for developing universal vaccine antigen (s) and vaccine (s) protecting Pandemic in the future 2021-09 25 1000500 China

INV-034554 Duke Kunshan University to support the exploration of innovative solution on implementation of vaccine introductions and improvement of the immunization programs at the national and regional levels 2021-09 25 1298906 China

INV-023665 Academy of Agricultural Planning and Engineering, Ministry of Agriculture and Rural A airs of the People’s Republic of China to fund demonstration platform in China for showcasing single-unit and multi-unit reinvented toilets (RT), and to validate the commercial and market acceptance of RT systems. 2021-09 21 2282000 China

INV-035442 University of Chinese Academy of Sciences to support research on R&D related policies, data regulations, data management, biomedical safety, and biomedical ethics in order to promote global health R&D and mitigate possible risks 2021-09 16 100000 China

INV-034871 National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research) to apply for South-South Cooperation Assistance Fund to ll in Global Fund’s gap on SMC supply for Children under ve in one African country in Sahel region 2021-09 28 200000 China

INV-035441 Shanghai Center of Biomedicine Development To accelerate vaccine development in Shanghai and Yangzi river Delta to address global health challenges in China and the world 2021-08 28 2650000 China

INV-034878 Beijing Qiyue Center for Philanthropy to generate systemic indicators for nonpro ts projects, to make it possible for collecting comparable data across nonpro ts to generate high quality result/impact analysis that inform giving decisions 2021-08 11 149997 China

INV-031019 The Third People‘s Hospital of Shenzhen to support the 3rd Global Health Symposium 2021-08 12 100000 China

INV-035249 Agricultural Information Institute of Chinese Academy of Agricultural Sciences to support targeted researches and consensus building activities for the drafting of China-Africa Ag Modernization Plan with the aim of better leveraging China’s expertise to facilitate Africa countries’ agricultural transformation2021-08 18 170410 China

INV-035023 Innovation Alliance on Tuberculosis Diagnosis and Treatment (Beijing) to support the organization of TB R&D international forum (2022-2024) to enhance the communication of TB R&D for Chinese scientists and international peers, and serve as a platform to promote TB R&D in China 2021-08 36 204465 China

INV-004964 PATH Shanghai Representative O ce to establish and maintain a dedicated, capable, and experienced tuberculosis (TB) expert team to provide technical assistance to support TB control in China 2021-08 37 600000 China

INV-034870 Zhongzhi Social Development Promotion Center to fund roundtable sessions, one-on-one consultations and workshops for UHNWIs, family o ces sta and wealth management professionals to facilitate their philanthropic decisions 2021-07 17 149070 China

INV-021880 China Center for Food and Drug International Exchange to support China’s medical products regulatory system to improve its regulatory capacity in pharmacovigilance 2021-07 47 3400000 China

INV-031637 National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention to improve the Children's nutrition and health in poor areas of China 2021-07 30 1286511 China

INV-031761 Development Reimagined to support African policy makers and leaders as they develop their strategic GH and GD priorities for FOCAC 2021 and beyond and ultimately deliver improved healthcare interventions to underserved populations through strengthened
2021-07 cooperation 6 104619 China

INV-031380 Tsinghua University to produce a discrete, comfortable, low-cost and sustainable menstrual product based on the suction cups of octopi that reversibly adheres inside the vaginal opening to block blood ow and enable controlled release for convenient
2021-07disposal 17 100000 China

INV-032021 Chinese Association of STD & AIDS Prevention and Control to support the local CDC system in Liangshan Prefecture for AIDS prevention and reduce the local rate of mother-to-child transmission of AIDS and the rate of new infections 2021-06 36 1000000 China

INV-030929 China CDC to support a landscape research on TB vaccines research and development and generate evidence to improve TB vaccine development and use in China 2021-05 24 100000 China

INV-032621 Asymchem Life Science (Tianjin) Co., Ltd. to enable a lower cost process for production of new APIs for TB treatment 2021-05 13 164420 China

INV-031301 PATH Shanghai Representative O ce To provide project management and technical assistance to NMPA project management o ce to ensure that NMPA-Gates Phase II project is implemented in line with the work plan and the outcomes are successfully achieved.
2021-05 36 640000 China

INV-017019 Shanghai Center for Pujiang Innovation Forum to create a cooperative platform and partnerships among key national and international stakeholders with Shanghai to address global health and global development challenges to ultimately serve the disadvantaged populations
2021-04 12 150000 China

INV-031017 Shanghai Center of Biomedicine Development to build up R&D partnership with Shanghai to address global health and agricultural challenges in China and the world 2021-04 24 500000 China

INV-030859 Chinese Academy of International Trade and Economic Cooperation to enable our grantee to conduct policy analysis and advocacy activities to promote China-Africa collaboration on Foundation's prioritized global health and global development issues at forthcoming FOCAC in 2021 2021-03 12 250000 China

INV-025841 Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences to design and engineering of a synthetic enzyme pathway from AA to Artemisinin 2021-01 24 800000 China

INV-026361 Wuhan University to provide scienti c evidence to policy makers to lower the price and improve multi- nancing policies of TB drugs that lead to improved accessibilities of high quality TB services and reduced nancial burden for TB patients 2021-01 7 127650 China

INV-027291 Shanghai Jiao Tong University To improve global market need for antimalaria treatment supply of artemisinin. 2021-01 18 299920 China

INV-025826 Innovation Alliance on Tuberculosis Diagnosis and Treatment (Beijing) To support the Innovation Alliance on Tuberculosis Diagnosis and Treatment to organize an international TB R&D forum to promote TB research in China and communications with international community. 2020-12 6 61855 China

INV-018912 Peking University To evaluate the impact of the Malaria Molecular Epi Lab Network Pilot Projects in Sierra Leone and to promote integration and adoption by the local government and China-Africa health cooperation program for project sustainability
2020-12 37 300000 China

INV-023808 Peking Union Medical College to establish a new research and postgraduate education platform of Global Health and Public Health for mitigating the challenges of Women and Children Immunization 2020-11 37 594000 China

INV-006407 Tsinghua University to fund practical research, capacity building, community cultivation and issue communication in the GH and GD space with the ultimate goal to help those who are su ering from infectious diseases, hunger and poverty. 2020-11 34 2500000 China

INV-006372 China CDC to support China CDC to develop and test the tobacco control monitoring indicators and systems and provide technical assistance to the relevant agencies to track the TC progress to better achieve Healthy China Initiative’s goals
2020-11 36 750000 China

INV-023018 Academy of Agricultural Planning and Engineering, Ministry of Agriculture and Rural A airs of the People’s Republic of China to establish a demonstration platform to showcase reinvented toilet and other innovative sanitation technologies and to investigate sustainable business models in preparation for industrial-scale adoption to make impact in poor
2020-11
communities 23 500000 China

INV-023809 Beijing New Sunshine Charity Foundation to fund a common fund which will engage local private and public founders in a joint e ort to set up a grant-making common fund post COVID-19 2020-10 23 635315 China

INV-018013 Shenzhen Health Development and Research Center to establish the “The Vaccine & Health Research Consortium” to fund and coordinate research on global health in China, with a focus on vaccine and immunization, to accelerate vaccine preventable disease and vaccine delivery
2020-10
research 26 684280 China

INV-019120 Chinese Academy of International Trade and Economic Cooperation to support China to develop the e ective multisectoral collaboration mechanisms for its Development Assistance for Health Program, with China-Africa Malaria program as an exemplar 2020-10 35 1082398 China

INV-006373 Chinese Preventive Medicine Association To strengthen the research of vaccine safety and pharmacovigilance for COVID-19 vaccine and NIP vaccine in China 2020-10 26 1079982 China

INV-023014 Institute of Plant Protection, Chinese Academy of Agricultural Sciences to generate learning from China's experience in establishing and improving early warning systems for major crops, which can be shared with less developed countries with such needs, especially in Sub-Saharan Africa 2020-10 21 349150 China

INV-004142 Beijing Cihong Charity Foundation to convene leading Chinese Convene Corporate Foundations to adopt and improve impact-data infrastructure and results measurement 2020-09 36 200694 China

INV-022394 PATH Shanghai Representative O ce to build up regional cooperative platform based on Pujiang Innovation Forum and to create R&D partnerships with Shanghai to address global health and global development challenges in China and the world 2020-09 19 300000 China

INV-017784 PATH Shanghai Representative O ce To create R&D partnerships with Shanghai to address global health and global development challenges in China and the world 2020-09 48 2400000 China

INV-022361 Ginkgo Foundation to provide general operating support 2020-09 12 50000 China

INV-022392 PATH Shanghai Representative O ce to build up R&D partnership with Shanghai to address global health and development challenges in China and the world 2020-09 22 150000 China

INV-017021 Shenzhen Health Development and Research Center to build up regional partnership with Shenzhen for joint e orts to promote local health capacity building and China’s engagement in global health 2020-09 25 149866 China

INV-017788 Foreign Talent Research Center, Ministry of Science and Technology of the People's Republic of China To research on CEPI and study on China's possible engagement in CEPI. 2020-09 15 100000 China

INV-019121 National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention to support China CDC to evaluate the quality of COVID-19 serological diagnostic reagents in China and provide evidence for scienti c use of reagents in clinical diagnosis and epidemiological survey 2020-08 13 71700 China

INV-022855 Asymchem Life Science (Tianjin) Co., Ltd. to enable a lower cost process for production of Remdesivir API 2020-08 5 141000 China

INV-004145 Central University of Finance and Economics to support policy research and advocacy work in China to ensure high quality implementation of existing tax policies and provide opinions for future improvement 2020-08 14 170000 China

INV-019124 National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention to summarize and document Chinese vector control experience and best practice for sharing with malaria epidemic countries 2020-08 25 130000 China

INV-018913 National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research) to summarize and share China malaria elimination experience in the past seven decades by documenting, lming and coordinating video shooting on China’s e orts 2020-08 23 450000 China

INV-004139 Peking University to support high quality research to better understand Chinese online donor behavior through big data analysis, sentiment analysis, social network mapping analysis, etc. 2020-08 37 197266 China

INV-017787 Shanghai Science and Technology Exchange Center to support a workshop to increase stakeholder’s awareness of global health and COVID-19 R&D importance and discuss prioritized R&D and clinical areas in the post-COVID-19 times 2020-08 11 130000 China

INV-018302 Tsinghua University to conduct a qualitative comparative analysis (QCA) of health system and develop a tabletop exercises to improve the response and preparedness to the pandemic 2020-08 24 153823 China

OPP1217414 Tsinghua University to establish a think tank to provide regulatory science research and technical support for vaccine ecosystem building suggestions 2020-08 24 300000 China

INV-018666 Beijing Guokr Interactive Technology Media Co. Ltd to cultivate and empower the digital in uencers and create a platform that ampli es the importance of advocating cross-cutting global health and development issues to ultimately help disadvantaged populations facing these 2020-07
challenges 36 550000 China

INV-017715 Beijing Normal University to provide in-depth and comprehensive research into the philanthropy in China and propose a development plan, by looking into its history, culture background, existing regulatory environment, and future trajectory 2020-07 20 100000 China

INV-015971 Narada Foundation to create a more conducive public opinion environment for nonpro ts’ long-term development and more inclusive policy environment for the sector to help people su ering from diseases, poverty, gender inequality and other social
2020-07
issues 26 141865 China

INV-003421 China CDC Support China CDC on Piloting project on building capacity of malaria molecular lab epidemiology network in Sierra Leone 2020-07 42 1800000 China

INV-017785 University of Chinese Academy of Sciences to research on how China better engage in CGIAR led multi-lateral partnership in Ag areas 2020-07 18 100000 China

INV-016183 Peking University to conduct policy studies to improve China's participation and engagement in global governance regarding public health security and emergency preparedness and responses 2020-06 4 200000 China

INV-006377 Institute of Microbiology, Chinese Academy of Sciences To support developing assays platform of drug screening and subunit vaccines of coronavirus, which will contribute to product innovation of COVID-19 pandemic control 2020-05 12 359820 China

INV-005379 Artepharm Co., Ltd., China to achieve WHO Pre-quali cation approval for AS-PQP by Artepharm 2020-05 40 1100812 China

INV-006406 Zhejiang University to engage China play a bigger role in global governance and to contribute more to GAVI 2020-05 15 120000 China

INV-002169 Yangzhou Pharmaceutical Co., Ltd. To achieve WHO Pre-quali cation approval for Yangzhou LNG API. 2020-05 37 1295100 China

INV-004900 Capital Medical University This investment will be used to support policy studies of provider payment and nancing of TB services in China 2020-05 36 580000 China

INV-006379 National Institutes for Food and Drug Control to support optimizing pseudovirus platforms for COVID-19 product innovation 2020-05 20 208575 China

INV-006445 Shanghai Zerun Biotechnology Co., Ltd. to support research and development for COVID-19 response 2020-05 12 1000000 China

INV-005832 China CDC to support emergency response and evaluation, and prepare China for the potential pandemic, which will not only help disease control and containment but contribute China’s experience to global health 2020-05 19 600000 China

INV-005837 China National Biotech Group Company Limited to support international collaboration on anti-coronavirus products to increase the availability of safe and e ective products for sustainable distribution and their use in China and the foundation’s target countries. 2020-04 32 400000 China

INV-006278 Ginkgo Foundation to support a series of action studies to summarize social organizations’ responses at the forefront of COVID-19 relief e orts and the implications for peer organization and future learning 2020-04 18 150000 China

INV-006376 Shenzhen Center for Disease Control and Prevention To support serological investigation in Shenzhen to assess resurging risks of COVID-19 or outbreaks and provide guidance on targeted outbreak response measures after the release of containment 2020-04 15 257250 China

INV-006277 Fudan University to support the epidemiology study and identify the high risks of COVID-19 infection, which will contribute to national and international public health intervention strategy and product development 2020-04 17 300000 China

INV-005838 CanSino Biologics Inc. to support international collaboration on development of anti-coronavirus vaccines, which will increase the availability of safe and e ective vaccines for sustainable, global distribution and use 2020-04 21 400000 China

INV-006261 Tsinghua University to provide evidence-based recommendations and technical assistance to improve China public health governance and system to better response to the pandemics such as COVID-19 outbreaks, in China and Globally 2020-04 24 1000000 China

INV-005374 Chinese Association of STD & AIDS Prevention and Control to carry out a series of national level publicity activities to promote HIV/AIDS and TB prevention and control in China 2020-04 36 1500000 China

INV-015694 Drug Clinical Trial Center in Peking University Third Hospital to advance the use of novel quantitative methods to support optimal use and approval of drugs in China 2020-03 12 453000 China

INV-006104 Xi’an Jiaotong University To support epidemiological prediction and risk assessment, which will facilitate an evidence-based decision-making and allocoation of medical resourses during the battle over COVID-19 outbreak 2020-03 22 100000 China

INV-006105 Sino Biological Inc. to support colloidal gold and ELISA diagnosis of COVID-19 to speed up innovation and increase the availability of e ective and large-scale products for the sustainable distribution and use in both China and Foundation’s target
2020-03
countries 6 200000 China

INV-006106 Shanghai ZJ Bio-Tech Co., Ltd. To support the post-licensure clinical evaluation and comparison studies of nucleic acid detection reagent to demonstrate the key factors impact the sensitivity and speci city of diagnostics reagents of COVID 2020-03 6 100000 China

INV-005834 Xiamen University to support innovation of vaccine and Point of Care Testing (POCT) through epitope identi cation, the modeling outputs of which will facilitate an evidence-based decision-making during the battle over 2019-nCoV outbreak 2020-03 13 600000 China

INV-005839 AbMax Biotechnology Co., Ltd. to speed up the innovation and increase the availability of e ective and large scale product for sustainable distribution and use in both China and Foundation’s target countries 2020-02 7 100000 China

INV-005840 The Third People‘s Hospital of Shenzhen To support the study of clinical epidemiology for 2019-nCoV outbreak and evaluation of IVD Diagnostics in China, which will contribute national and international public health intervention strategy development to against 2019-nCoV
2020-02 17 500000 China

INV-006080 Guangzhou Institute of Respiratory Health to develop a model to manage NCP assumptive and con rmed cases through an integrated healthcare approach for the patient treatment and quarantine. 2020-02 21 199653 China

INV-003422 Landcent (China) Industrial & Development Co. Ltd. to fund the development & discovery of Novel Active Ingredients (AI)from Traditional Chinese Medicine (TCM) library for use in Vector Control originating to formulate these AIs into Insecticides & other potential solutions 2020-01 24 1302050 China
fi
fi
fi
fi
ffi
ffi
ffi
ffi
ffi
ff
fl
fi
ff
fi
fi
ff
fi
fi
fi
fi
ff
ff
ff
fi
ffi
ffi
ff
fi
ff
ff
fi
ff
fi
ff
fi
ff
ff
ff
fi
fi
fl
ff
fi
ffi